approval · primary record
PLOZASIRAN SODIUM
FDA · NDA · 2025-11-18
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-11-18 |
| Brand | REDEMPLO |
| Sponsor | ARROWHEAD |
| Route | SUBCUTANEOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:30:39.868Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:PLOZASIRAN SODIUM:2025-11-18
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.